Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
The merger comes as the acetaminophen drug faces scrutiny from the Trump administration and a lawsuit from Texas.
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback